Atrial fibrillation in chronic dialysis patients in the United states: risk factors for hospitalization and mortality

go back to reference Zebe H: Atrial fibrillation in dialysis patients. Nephrol Dial Transplant. 2000, 15: 765-8. 10.1093/ndt/15.6.765.CrossRefPubMed Zebe H: Atrial fibrillation in dialysis patients. Nephrol Dial Transplant. 2000, 15: 765-8. 10.1093/ndt/15.6.765.CrossRefPubMed

go back to reference Foley RN, Parfrey PS, Kent GM, Harnett JD, Murray DC, Barre PE: Long-term evolution of cardiomyopathy in dialysis patients. Kidney Int. 1998, 54: 1720-5. 10.1046/j.1523-1755.1998.00154.x.CrossRefPubMed Foley RN, Parfrey PS, Kent GM, Harnett JD, Murray DC, Barre PE: Long-term evolution of cardiomyopathy in dialysis patients. Kidney Int. 1998, 54: 1720-5. 10.1046/j.1523-1755.1998.00154.x.CrossRefPubMed

go back to reference Ansari N, Manis T, Feinfeld DA: Symptomatic atrial arrhythmias in hemodialysis patients. Ren Fail. 2001, 23: 71-6. 10.1081/JDI-100001285.CrossRefPubMed Ansari N, Manis T, Feinfeld DA: Symptomatic atrial arrhythmias in hemodialysis patients. Ren Fail. 2001, 23: 71-6. 10.1081/JDI-100001285.CrossRefPubMed

go back to reference Fabbian F, Catalano C, Lambertini D, Tarroni G, Bordin V, Squerzanti R, Gilli P, Di Landro D, Cavagna R: Clinical characteristics associated to atrial fibrillation in chronic hemodialysis patients. Clin Nephrol. 2000, 54: 234-9.PubMed Fabbian F, Catalano C, Lambertini D, Tarroni G, Bordin V, Squerzanti R, Gilli P, Di Landro D, Cavagna R: Clinical characteristics associated to atrial fibrillation in chronic hemodialysis patients. Clin Nephrol. 2000, 54: 234-9.PubMed

go back to reference Vazquez E, Sanchez-Perales C, Borrego F, Garcia-Cortes MJ, Lozano C, Guzman M, Gil JM, Borrego MJ, Perez V: Influence of atrial fibrillation on the morbido-mortality of patients on hemodialysis. Am Heart J. 2000, 140: 886-90. 10.1067/mhj.2000.111111.CrossRefPubMed Vazquez E, Sanchez-Perales C, Borrego F, Garcia-Cortes MJ, Lozano C, Guzman M, Gil JM, Borrego MJ, Perez V: Influence of atrial fibrillation on the morbido-mortality of patients on hemodialysis. Am Heart J. 2000, 140: 886-90. 10.1067/mhj.2000.111111.CrossRefPubMed

go back to reference SPAF Investigators: The Stroke Prevention in Atrial Fibrillation Study Group Investigators: final results. Circulation. 1991, 84: 527-39.CrossRef SPAF Investigators: The Stroke Prevention in Atrial Fibrillation Study Group Investigators: final results. Circulation. 1991, 84: 527-39.CrossRef

go back to reference Stroke Prevention in Atrial Fibrillation investigators: Adjusted-dose warfarin versus low-intensity, fixed-dose warfarin plus aspirin for high-risk patients with atrial fibrillation: Stroke Prevention in Atrial Fibrillation III randomised clinical trial. Lancet. 1996, 348: 633-8. 10.1016/S0140-6736(96)03487-3.CrossRef Stroke Prevention in Atrial Fibrillation investigators: Adjusted-dose warfarin versus low-intensity, fixed-dose warfarin plus aspirin for high-risk patients with atrial fibrillation: Stroke Prevention in Atrial Fibrillation III randomised clinical trial. Lancet. 1996, 348: 633-8. 10.1016/S0140-6736(96)03487-3.CrossRef

go back to reference Stack AG, Bloembergen WE: Prevalence and clinical correlates of coronary artery disease among new dialysis patients in the United States: a cross-sectional study. J Am Soc Nephrol. 2001, 12: 1516-23.PubMed Stack AG, Bloembergen WE: Prevalence and clinical correlates of coronary artery disease among new dialysis patients in the United States: a cross-sectional study. J Am Soc Nephrol. 2001, 12: 1516-23.PubMed

go back to reference Stack AG, Bloembergen WE: A cross-sectional study of the prevalence and clinical correlates of congestive heart failure among incident US dialysis patients. Am J Kidney Dis. 2001, 38: 992-1000.CrossRefPubMed Stack AG, Bloembergen WE: A cross-sectional study of the prevalence and clinical correlates of congestive heart failure among incident US dialysis patients. Am J Kidney Dis. 2001, 38: 992-1000.CrossRefPubMed

go back to reference Stehman-Breen CO, Gillen D, Gipson D: Prescription of hormone replacement therapy in postmenopausal women with renal failure. Kidney Int. 1999, 56: 2243-7. 10.1046/j.1523-1755.1999.00793.x.CrossRefPubMed Stehman-Breen CO, Gillen D, Gipson D: Prescription of hormone replacement therapy in postmenopausal women with renal failure. Kidney Int. 1999, 56: 2243-7. 10.1046/j.1523-1755.1999.00793.x.CrossRefPubMed

go back to reference Stehman-Breen CO, Sherrard DJ, Gillen D, Caps M: Determinants of type and timing of initial permanent hemodialysis vascular access. Kidney Int. 2000, 57: 639-45. 10.1046/j.1523-1755.2000.00885.x.CrossRefPubMed Stehman-Breen CO, Sherrard DJ, Gillen D, Caps M: Determinants of type and timing of initial permanent hemodialysis vascular access. Kidney Int. 2000, 57: 639-45. 10.1046/j.1523-1755.2000.00885.x.CrossRefPubMed

go back to reference [No authors listed]: Medication use among dialysis patients in the DMMS. United States Renal Data System. Dialysis Morbidity and Mortality Study. Am J Kidney Dis. 1998, 32 (2 Suppl 1): S60-8. [No authors listed]: Medication use among dialysis patients in the DMMS. United States Renal Data System. Dialysis Morbidity and Mortality Study. Am J Kidney Dis. 1998, 32 (2 Suppl 1): S60-8.

go back to reference Fung F, Sherrard DJ, Gillen DL, Wong C, Kestenbaum B, Seliger S, Ball A, Stehman-Breen C: Increased risk for cardiovascular mortality among malnourished end-stage renal disease patients. Am J Kidney Dis. 2002, 40: 307-14. 10.1053/ajkd.2002.34509.CrossRefPubMed Fung F, Sherrard DJ, Gillen DL, Wong C, Kestenbaum B, Seliger S, Ball A, Stehman-Breen C: Increased risk for cardiovascular mortality among malnourished end-stage renal disease patients. Am J Kidney Dis. 2002, 40: 307-14. 10.1053/ajkd.2002.34509.CrossRefPubMed

go back to reference Seliger SL, Weiss NS, Gillen DL, Kestenbaum B, Ball A, Sherrard DJ, Stehman-Breen CO: HMG-CoA reductase inhibitors are associated with reduced mortality in ESRD patients. Kidney Int. 2002, 61: 297-304. 10.1046/j.1523-1755.2002.00109.x.CrossRefPubMed Seliger SL, Weiss NS, Gillen DL, Kestenbaum B, Ball A, Sherrard DJ, Stehman-Breen CO: HMG-CoA reductase inhibitors are associated with reduced mortality in ESRD patients. Kidney Int. 2002, 61: 297-304. 10.1046/j.1523-1755.2002.00109.x.CrossRefPubMed

go back to reference Kestenbaum B, Gillen DL, Sherrard DJ, Seliger S, Ball A, Stehman-Breen C: Calcium channel blocker use and mortality among patients with end-stage renal disease. Kidney Int. 2002, 61: 2157-64. 10.1046/j.1523-1755.2002.00355.x.CrossRefPubMed Kestenbaum B, Gillen DL, Sherrard DJ, Seliger S, Ball A, Stehman-Breen C: Calcium channel blocker use and mortality among patients with end-stage renal disease. Kidney Int. 2002, 61: 2157-64. 10.1046/j.1523-1755.2002.00355.x.CrossRefPubMed

go back to reference Trespalacios FC, Taylor AJ, Agodoa LY, Abbott KC: Incident acute coronary syndromes in chronic dialysis patients in the United States. Kidney Int. 2002, 62: 1799-1805. 10.1046/j.1523-1755.2002.00638.x.CrossRefPubMed Trespalacios FC, Taylor AJ, Agodoa LY, Abbott KC: Incident acute coronary syndromes in chronic dialysis patients in the United States. Kidney Int. 2002, 62: 1799-1805. 10.1046/j.1523-1755.2002.00638.x.CrossRefPubMed

go back to reference Szklo M, Nieto FJ: Epidemiology: Beyond the Basics. Chapter 7, "Stratification and Adjustment: Multivariate Analysis in Epidemiology," page 257. © Aspen Publishers, Gaithersburg, MD. 2000 Szklo M, Nieto FJ: Epidemiology: Beyond the Basics. Chapter 7, "Stratification and Adjustment: Multivariate Analysis in Epidemiology," page 257. © Aspen Publishers, Gaithersburg, MD. 2000

go back to reference Hypolite IO, Bucci J, Hshieh P, Cruess D, Agodoa LY, Yuan CM, Taylor AJ, Abbott KC: Acute coronary syndromes after renal transplantation in patients with end-stage renal disease resulting from diabetes. Am J Transplant. 2002, 2: 274-81. 10.1034/j.1600-6143.2002.20313.x.CrossRefPubMed Hypolite IO, Bucci J, Hshieh P, Cruess D, Agodoa LY, Yuan CM, Taylor AJ, Abbott KC: Acute coronary syndromes after renal transplantation in patients with end-stage renal disease resulting from diabetes. Am J Transplant. 2002, 2: 274-81. 10.1034/j.1600-6143.2002.20313.x.CrossRefPubMed

go back to reference David Kleinbaum: Survival Analysis : A Self-Learning Text (Statistics in the Health Sciences) Springer Verlag; New York, New York. May 1996 David Kleinbaum: Survival Analysis : A Self-Learning Text (Statistics in the Health Sciences) Springer Verlag; New York, New York. May 1996

go back to reference Mehta RL, McDonald B, Gabbai F, Pahl M, Farkas A, Pascual MT, Zhuang S, Kaplan RM, Chertow GM: Nephrology consultation in acute renal failure: does timing matter?. Am J Med. 2002, 113: 456-61. 10.1016/S0002-9343(02)01230-5.CrossRefPubMed Mehta RL, McDonald B, Gabbai F, Pahl M, Farkas A, Pascual MT, Zhuang S, Kaplan RM, Chertow GM: Nephrology consultation in acute renal failure: does timing matter?. Am J Med. 2002, 113: 456-61. 10.1016/S0002-9343(02)01230-5.CrossRefPubMed

go back to reference Stata corporation. [http://www.iue.it/Personal/Ichino/psj7.pdf] Stata corporation. [http://​www.​iue.​it/​Personal/​Ichino/​psj7.​pdf]

go back to reference Wattigney WA, Mensah GA, Croft JB: Increased atrial fibrillation mortality: United States, 1980–1998. Am J Epidemiol. 2002, 155: 819-26. 10.1093/aje/155.9.819.CrossRefPubMed Wattigney WA, Mensah GA, Croft JB: Increased atrial fibrillation mortality: United States, 1980–1998. Am J Epidemiol. 2002, 155: 819-26. 10.1093/aje/155.9.819.CrossRefPubMed

go back to reference Casserly LF, Reddy SM, Dember LM: Venous thromboembolism in end-stage renal disease. Am J Kidney Dis. 2000, 36: 405-11.CrossRefPubMed Casserly LF, Reddy SM, Dember LM: Venous thromboembolism in end-stage renal disease. Am J Kidney Dis. 2000, 36: 405-11.CrossRefPubMed

go back to reference Tveit DP, Hypolite IO, Hshieh P, Cruess D, Agodoa LY, Welch PG, Abbott KC: Chronic dialysis patients have high risk for pulmonary embolism. Am J Kidney Dis. 2002, 39: 1011-7. 10.1053/ajkd.2002.32774.CrossRefPubMed Tveit DP, Hypolite IO, Hshieh P, Cruess D, Agodoa LY, Welch PG, Abbott KC: Chronic dialysis patients have high risk for pulmonary embolism. Am J Kidney Dis. 2002, 39: 1011-7. 10.1053/ajkd.2002.32774.CrossRefPubMed

go back to reference Tveit DP, Hshieh P, Cruess D, Agodoa LY, Welch PG, Abbott KC: Risk factors for pulmonary embolism in chronic dialysis patients. J Nephrol. 2002, 15: 241-7.PubMed Tveit DP, Hshieh P, Cruess D, Agodoa LY, Welch PG, Abbott KC: Risk factors for pulmonary embolism in chronic dialysis patients. J Nephrol. 2002, 15: 241-7.PubMed

go back to reference Fumagalli S, Boncinelli L, Bondi E, Caleri V, Gatto S, Di Bari M, Baldereschi G, Valoti P, Masotti G, Marchionni N: Does advanced age affect the immediate and long-term results of direct-current external cardioversion of atrial fibrillation?. J Am Geriatr Soc. 2002, 50: 1192-7. 10.1046/j.1532-5415.2002.50304.x.CrossRefPubMed Fumagalli S, Boncinelli L, Bondi E, Caleri V, Gatto S, Di Bari M, Baldereschi G, Valoti P, Masotti G, Marchionni N: Does advanced age affect the immediate and long-term results of direct-current external cardioversion of atrial fibrillation?. J Am Geriatr Soc. 2002, 50: 1192-7. 10.1046/j.1532-5415.2002.50304.x.CrossRefPubMed

go back to reference Asinger RW: Role of transthoracic echocardiography in atrial fibrillation. Echocardiography. 2000, 17: 357-64.CrossRefPubMed Asinger RW: Role of transthoracic echocardiography in atrial fibrillation. Echocardiography. 2000, 17: 357-64.CrossRefPubMed

go back to reference Tozawa M, Iseki K, Iseki C, Takishita S: Pulse pressure and risk of total mortality and cardiovascular events in patients on chronic hemodialysis. Kidney Int. 2002, 61: 717-26. 10.1046/j.1523-1755.2002.00173.x.CrossRefPubMed Tozawa M, Iseki K, Iseki C, Takishita S: Pulse pressure and risk of total mortality and cardiovascular events in patients on chronic hemodialysis. Kidney Int. 2002, 61: 717-26. 10.1046/j.1523-1755.2002.00173.x.CrossRefPubMed

go back to reference Takeda K, Nakamoto M, Baba M, Tanaka T, Yasunaga C, Nishihara G, Matsuo K, Urabe M: Echocardiographic evaluation in long-term continuous ambulatory peritoneal dialysis compared with the hemodialysis patients. Clin Nephrol. 1998, 49: 308-12.PubMed Takeda K, Nakamoto M, Baba M, Tanaka T, Yasunaga C, Nishihara G, Matsuo K, Urabe M: Echocardiographic evaluation in long-term continuous ambulatory peritoneal dialysis compared with the hemodialysis patients. Clin Nephrol. 1998, 49: 308-12.PubMed

go back to reference Covic A, Goldsmith DJ, Georgescu G, Venning MC, Ackrill P: Echocardiographic findings in long-term, long-hour hemodialysis patients. Clin Nephrol. 1996, 45: 104-10.PubMed Covic A, Goldsmith DJ, Georgescu G, Venning MC, Ackrill P: Echocardiographic findings in long-term, long-hour hemodialysis patients. Clin Nephrol. 1996, 45: 104-10.PubMed

go back to reference Abbott KC, Hypolite IO, Hshieh P, Cruess D, Agodoa LY, Welch PG, Taylor AJ, Yuan CM: The impact of renal transplantation on the incidence of congestive heart failure in patients with end-stage renal disease due to diabetes. J Nephrol. 2001, 14: 369-76.PubMed Abbott KC, Hypolite IO, Hshieh P, Cruess D, Agodoa LY, Welch PG, Taylor AJ, Yuan CM: The impact of renal transplantation on the incidence of congestive heart failure in patients with end-stage renal disease due to diabetes. J Nephrol. 2001, 14: 369-76.PubMed

go back to reference Buoncristiani U, Fagugli R, Ciao G, Ciucci A, Carobi C, Quintaliani G, Pasini P: Left ventricular hypertrophy in daily dialysis. Miner Electrolyte Metab. 1999, 25: 90-4. 10.1159/000057427.CrossRefPubMed Buoncristiani U, Fagugli R, Ciao G, Ciucci A, Carobi C, Quintaliani G, Pasini P: Left ventricular hypertrophy in daily dialysis. Miner Electrolyte Metab. 1999, 25: 90-4. 10.1159/000057427.CrossRefPubMed

go back to reference Jansen MA, Hart AA, Korevaar JC, Dekker FW, Boeschoten EW, Krediet RT: Predictors of the rate of decline of residual renal function in incident dialysis patients. Kidney Int. 2002, 62: 1046-1053. 10.1046/j.1523-1755.2002.00505.x.CrossRefPubMed Jansen MA, Hart AA, Korevaar JC, Dekker FW, Boeschoten EW, Krediet RT: Predictors of the rate of decline of residual renal function in incident dialysis patients. Kidney Int. 2002, 62: 1046-1053. 10.1046/j.1523-1755.2002.00505.x.CrossRefPubMed

go back to reference Lip GY, Tean KN, Dunn FG: Treatment of atrial fibrillation in a district general hospital. Br Heart J. 1994, 71: 92-5.CrossRefPubMedPubMedCentral Lip GY, Tean KN, Dunn FG: Treatment of atrial fibrillation in a district general hospital. Br Heart J. 1994, 71: 92-5.CrossRefPubMedPubMedCentral

go back to reference Wiesholzer M, Harm F, Tomasec G, Barbieri G, Putz D, Balcke P: Incidence of stroke among chronic hemodialysis patients with nonrheumatic atrial fibrillation. Am J Nephrol. 2001, 21: 35-9. 10.1159/000046216.CrossRefPubMed Wiesholzer M, Harm F, Tomasec G, Barbieri G, Putz D, Balcke P: Incidence of stroke among chronic hemodialysis patients with nonrheumatic atrial fibrillation. Am J Nephrol. 2001, 21: 35-9. 10.1159/000046216.CrossRefPubMed

go back to reference Oda H, Ohno M, Ohashi H: Coagulation and fibrinolysis factors in dialysis patients with and without ischemic heart disease. Adv Perit Dial. 2000, 16: 152-5.PubMed Oda H, Ohno M, Ohashi H: Coagulation and fibrinolysis factors in dialysis patients with and without ischemic heart disease. Adv Perit Dial. 2000, 16: 152-5.PubMed

go back to reference Lottermoser K, Petras S, Poge U, Fimmers R, Hertfelder HJ, Schiermeyer B, Vetter H, Dusing R: The fibrinolytic system in chronic renal failure. Eur J Med Res. 2001, 6: 372-6.PubMed Lottermoser K, Petras S, Poge U, Fimmers R, Hertfelder HJ, Schiermeyer B, Vetter H, Dusing R: The fibrinolytic system in chronic renal failure. Eur J Med Res. 2001, 6: 372-6.PubMed

go back to reference Al-Khadra AS, Salem DN, Rand WM, Udelson JE, Smith JJ, Konstam MA: Warfarin anticoagulation and survival: a cohort analysis from the Studies of Left Ventricular Dysfunction. J Am Coll Cardiol. 1998, 31: 749-53. 10.1016/S0735-1097(98)00006-0.CrossRefPubMed Al-Khadra AS, Salem DN, Rand WM, Udelson JE, Smith JJ, Konstam MA: Warfarin anticoagulation and survival: a cohort analysis from the Studies of Left Ventricular Dysfunction. J Am Coll Cardiol. 1998, 31: 749-53. 10.1016/S0735-1097(98)00006-0.CrossRefPubMed

go back to reference Fuster V, Ryden LE, Asinger RW, Cannom DS, Crijns HJ, Frye RL, Halperin JL, Kay GN, Klein WW, Levy S, McNamara RL, Prystowsky EN, Wann LS, Wyse DG, Gibbons RJ, Antman EM, Alpert JS, Faxon DP, Fuster V, Gregoratos G, Hiratzka LF, Jacobs AK, Russell RO, Smith SC, Klein WW, Alonso-Garcia A, Blomstrom-Lundqvist C, de Backer G, Flather M, Hradec J, Oto A, Parkhomenko A, Silber S, Torbicki A: ACC/AHA/ESC Guidelines for the Management of Patients With Atrial Fibrillation: Executive Summary A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to Develop Guidelines for the Management of Patients With Atrial Fibrillation) Developed in Collaboration With the North American Society of Pacing and Electrophysiology. Circulation. 2001, 104 (17): 2118-50.PubMed Fuster V, Ryden LE, Asinger RW, Cannom DS, Crijns HJ, Frye RL, Halperin JL, Kay GN, Klein WW, Levy S, McNamara RL, Prystowsky EN, Wann LS, Wyse DG, Gibbons RJ, Antman EM, Alpert JS, Faxon DP, Fuster V, Gregoratos G, Hiratzka LF, Jacobs AK, Russell RO, Smith SC, Klein WW, Alonso-Garcia A, Blomstrom-Lundqvist C, de Backer G, Flather M, Hradec J, Oto A, Parkhomenko A, Silber S, Torbicki A: ACC/AHA/ESC Guidelines for the Management of Patients With Atrial Fibrillation: Executive Summary A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to Develop Guidelines for the Management of Patients With Atrial Fibrillation) Developed in Collaboration With the North American Society of Pacing and Electrophysiology. Circulation. 2001, 104 (17): 2118-50.PubMed

go back to reference Korzets A, Ori Y, Herman M: Serum potassium levels and atrial fibrillation in haemodialysis patients. Nephrol Dial Transplant. 2001, 16: 1090-10.1093/ndt/16.5.1090. LetterCrossRefPubMed Korzets A, Ori Y, Herman M: Serum potassium levels and atrial fibrillation in haemodialysis patients. Nephrol Dial Transplant. 2001, 16: 1090-10.1093/ndt/16.5.1090. LetterCrossRefPubMed

go back to reference Abbott KC, Agodoa LY: Hospitalizations for valvular heart disease in chronic dialysis patients in the United States. Nephron. 2002, 92: 43-50. 10.1159/000064476.CrossRefPubMed Abbott KC, Agodoa LY: Hospitalizations for valvular heart disease in chronic dialysis patients in the United States. Nephron. 2002, 92: 43-50. 10.1159/000064476.CrossRefPubMed

go back to reference Schall LC, Buchanich JM, Marsh GM, Bittner GM: Utilizing multiple vital status tracing services optimizes mortality follow-up in large cohort studies. Ann Epidemiol. 2001, 11: 292-296. 10.1016/S1047-2797(00)00217-9.CrossRefPubMed Schall LC, Buchanich JM, Marsh GM, Bittner GM: Utilizing multiple vital status tracing services optimizes mortality follow-up in large cohort studies. Ann Epidemiol. 2001, 11: 292-296. 10.1016/S1047-2797(00)00217-9.CrossRefPubMed